FTC Assesses Impact of 6 Years of Pay-for-Delay Drug Settlements

WHO: FTC Chairman Jon Leibowitz
will join
U.S. Representative Chris Van Hollen
U.S. Representative Bobby Rush
U.S. Representative Mary Jo Kilroy
Mr. G. Don Gading, of Bloomington, Indiana, a retiree who uses a drug that is only available in branded form due to a pay-for-delay settlement agreement that has kept a generic version off the market. Due to the high price of the branded drug, which he is taking under doctor’s orders, he recently began cutting the dose he takes in half to make his prescriptions last longer. WHAT: Press conference to announce an FTC staff analysis showing that pay-for-delay deals between brand and generic drug companies are costing American consumers billions a year, and to encourage inclusion of the House-passed pay-for-delay provision in the final version of the health care reform bill. WHEN: 12:30 P.M.
Wednesday, January 13, 2010 WHERE: Rayburn House Office Building
Room B-318 PRESS CONTACT: Office of Public Affairs

Leave a comment

Your email address will not be published. Required fields are marked *